Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 2
Review
Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,043 | Dovepress* | 7,043+ | 1,635 | 8,678 | |
Totals | 7,043 | 1,635 | 8,678 | ||
*Since 11 April 2008 +Since July 2016 |
View citations on Google Scholar